Salix Pharmaceuticals Financial Market Data
| Last Close 14-Aug-2008 |
$8.85 |
Price/ Sales Ratio |
2.31 |
| 52-Week High |
$14.26 |
Price/ Book Ratio |
1.60 |
| 52-Week Low |
$5.40 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
1.7 |
Price/ Cash Flow Ratio |
9.01 |
| Market Cap (mil.) |
$423.0 |
Return on Assets |
(10.2%) |
| Shares Outstanding (mil.) |
47.8 |
Return on Equity |
(12.9%) |
| Dividend Rate |
-- |
Current Ratio |
2.22 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.07 |
| # of Institutional Holders |
150 |
% Owned by Institutions |
112.0% |
| Latest Short Interest Ratio |
42.01 |
Latest Net Insider Transactions |
165,711.00 |
| Revenue Growth |
(25.0%) |
44.2% |
310.6% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
